PLATELET SEROTONIN TRANSPORT IS ALTERED IN STREPTOZOTOCIN-INDUCED DIABETIC RATS

被引:27
作者
MARTIN, FJ
MIGUEZ, JM
ALDEGUNDE, M
ATIENZA, G
机构
[1] UNIV SANTIAGO DE COMPOSTELA,FAC BIOL,DEPT FISIOL,E-15706 SANTIAGO,SPAIN
[2] HOSP MONTECELO,PONTEVEDRA,SPAIN
关键词
SEROTONIN; STREPTOZOTOCIN; DIABETES MELLITUS; PLATELET UPTAKE;
D O I
10.1016/0024-3205(95)00152-V
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present work was conducted to examine whether experimental diabetes (streptozotocin-induced) promotes changes in mean platelet volume, and platelet serotonin (5HT) uptake and content. These variables were measured in from four experimental groups: control, diabetic, diabetic+insulin, and non-diabetic+insulin. Animals treated fifteen days before with streptozotocin had platelets with higher 5HT uptake affinity, 5HT content, and volume. The insulin therapy reestablished the control values of all of these three variables. Non-diabetic animals treated one week with insulin did not show any variations. The effects of in vitro application of insulin, hyperglycaemic incubation medium, and streptozotocin on platelet amine uptake and release were also examined. Only those platelets incubated with streptozotocin showed an altered platelet 5HT uptake. No changes were observed for spontaneous 5HT release. The results are consistent with: a) an increase of platelet uptake capacity, as a consequence of an increase in platelet turnover, for explaining alterations of intraplatelet 5HT contents in experimental diabetes; b) a non-direct effect of insulin and glucose levels on platelet 5HT uptake -for explaining its dysfunctions in experimental diabetes-; c) the contribution of alterations in platelet 5HT transport for explaining the higher incidence of vascular complications in diabetic patients; d) the suitability of platelet as a model for investigating neuronal 5HT reuptake.
引用
收藏
页码:1807 / 1815
页数:9
相关论文
共 29 条
[1]  
ANDERSON GM, 1981, CLIN CHEM, V27, P775
[2]   INTRAPLATELET SEROTONIN IN PATIENTS WITH DIABETES-MELLITUS AND PERIPHERAL VASCULAR-DISEASE [J].
BARRADAS, MA ;
GILL, DS ;
FONSECA, VA ;
MIKHAILIDIS, DP ;
DANDONA, P .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (04) :399-404
[3]  
BARRADAS MA, 1992, BRAZ J MED BIOL RES, V25, P1063
[4]  
COLWELL JA, 1978, MED CLIN N AM, V62, P53
[5]  
DECLERCK F, 1991, J CARDIOVASC PHARM, V17, pS1
[6]  
DECLERCK F, 1989, BLOOD CELLS ARTERIES, P105
[7]   EFFECT OF STREPTOZOTOCIN DIABETES ON PLATELET-FUNCTION IN RATS [J].
ELDOR, A ;
MERIN, S ;
BARON, H .
THROMBOSIS RESEARCH, 1978, 13 (05) :703-714
[8]   STREPTOZOTOCIN AND ALLOXAN PRODUCE ALTERATIONS IN RAT-BRAIN MONOAMINES INDEPENDENTLY OF PANCREATIC BETA-CELLS DESTRUCTION [J].
LACKOVIC, Z ;
SALKOVIC, M .
LIFE SCIENCES, 1990, 46 (01) :49-54
[9]   PRIMARY STRUCTURE OF THE HUMAN PLATELET SEROTONIN UPTAKE SITE - IDENTITY WITH THE BRAIN-SEROTONIN TRANSPORTER [J].
LESCH, KP ;
WOLOZIN, BL ;
MURPHY, DL ;
RIEDERER, P .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) :2319-2322
[10]  
Martin F. J., 1995, Life Sciences, V56, P51